Potential impact of accelerating the primary dose of rotavirus vaccine in infants.
about
Public health impact of accelerated immunization against rotavirus infection among children aged less than 6 months in the United States.Open-Label Pilot Study to Compare the Safety and Immunogenicity of Pentavalent Rotavirus Vaccine (RV5) Administered on an Early Alternative Dosing Schedule with Those of RV5 Administered on the Recommended Standard Schedule.
P2860
Potential impact of accelerating the primary dose of rotavirus vaccine in infants.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Potential impact of accelerating the primary dose of rotavirus vaccine in infants.
@ast
Potential impact of accelerating the primary dose of rotavirus vaccine in infants.
@en
type
label
Potential impact of accelerating the primary dose of rotavirus vaccine in infants.
@ast
Potential impact of accelerating the primary dose of rotavirus vaccine in infants.
@en
prefLabel
Potential impact of accelerating the primary dose of rotavirus vaccine in infants.
@ast
Potential impact of accelerating the primary dose of rotavirus vaccine in infants.
@en
P2093
P2860
P1433
P1476
Potential impact of accelerating the primary dose of rotavirus vaccine in infants.
@en
P2093
Beverly M Snively
Elizabeth E Halvorson
Katherine A Poehling
Timothy R Peters
P2860
P304
P356
10.1016/J.VACCINE.2012.02.032
P407
P577
2012-02-26T00:00:00Z